NASDAQ: MLYS · Health Care / Biotechnology: Pharmaceutical Preparations

Mineralys Therapeutics Inc.

How Mineralys Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.9B

Price

$21.24

P/E

-5.4

EPS (TTM)

$-3.96

1-year return

-47.1%

Dividend yield

0.0%

52-week range

$20.30–$41.87

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources